BFONX
Price
$18.11
Change
-$0.85 (-4.48%)
Updated
Apr 10 closing price
Net Assets
45.83M
GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

BFONX vs GFACX

Header iconBFONX vs GFACX Comparison
Open Charts BFONX vs GFACXBanner chart's image
Biondo Focus Investor
Price$18.11
Change-$0.85 (-4.48%)
VolumeN/A
Net Assets45.83M
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
BFONX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BFONX vs. GFACX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFONX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. BFONX (45.8M). BFONX pays higher dividends than GFACX: BFONX (0.24) vs GFACX (0.00). BFONX was incepted earlier than GFACX: BFONX (15 years) vs GFACX (24 years). BFONX (1.72) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. BFONX (8.00). GFACX has a lower initial minimum investment than BFONX: GFACX (250) vs BFONX (1000). GFACX annual gain was more profitable for investors over the last year : -3.95 vs. BFONX (-8.04). GFACX return over 5 years is better than : 40.74 vs. BFONX (17.50).
BFONXGFACXBFONX / GFACX
Total Expense Ratio1.511.36111%
Annual Report Gross Expense Ratio1.721.36126%
Fund Existence15 years24 years-
Gain YTD-11.855-7.732153%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets45.8M272B0%
Annual Yield % from dividends0.240.00-
Returns for 1 year-8.04-3.95203%
Returns for 3 years-3.214.35-74%
Returns for 5 years17.5040.7443%
Returns for 10 years16.2738.8242%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings